HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Pool Selected Research

Martin Pool Research Topics

Disease

9Neoplasms (Cancer)
01/2023 - 08/2015
2Breast Neoplasms (Breast Cancer)
01/2023 - 11/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017 - 07/2017
1Neoplasm Metastasis (Metastasis)
01/2023
1Residual Neoplasm
01/2023
1Margins of Excision
01/2023
1Thyroid Neoplasms (Thyroid Cancer)
12/2022
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2019
1Leukemia
01/2016
1Bites and Stings (Sting)
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

5ErbB Receptors (EGF Receptor)IBA
01/2019 - 08/2015
3Tyrosine Kinase InhibitorsIBA
12/2022 - 08/2017
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2023 - 01/2016
2Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2017
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 08/2017
2Monoclonal AntibodiesIBA
07/2017 - 10/2016
2Cetuximab (Erbitux)FDA Link
07/2017 - 08/2015
2IRDye 800CWIBA
01/2016 - 08/2015
1CathepsinsIBA
01/2023
1Cysteine (L-Cysteine)FDA Link
01/2023
1lenvatinibIBA
12/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2022
1Zirconium-89IBA
11/2017
1Lapatinib (GW572016)FDA Link
11/2017
1human ERBB2 proteinIBA
11/2017
1LigandsIBA
08/2017
1onartuzumabIBA
08/2017
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2017
1imgatuzumabIBA
07/2017
1Epithelial Cell Adhesion MoleculeIBA
01/2016
1pertuzumabIBA
08/2015
1Epidermal Growth Factor (EGF)IBA
08/2015

Therapy/Procedure

2Therapeutics
12/2022 - 01/2019
1Segmental Mastectomy (Lumpectomy)
01/2023
1Radiotherapy
01/2023
1Drug Tapering
12/2022
1Radioimmunotherapy
01/2022
1Intravenous Administration
01/2016